Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy : a multicentre, parallel, randomised, controlled, phase 3 trial

Turner, S, Cotton, S, Wood, J, Bell, V, Raja, E A, Scott, N, Morgan, H, Lawrie, L, Emele, D, Kennedy, C, Scotland, G, Fielding, S, MacLennan, G, Norrie, J, Forrest, M, Gaillard, E A, de Jongste, J C, Pijnenburg, M W, Thomas, M & Price, D 2022, 'Reducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy : a multicentre, parallel, randomised, controlled, phase 3 trial', The Lancet. Respiratory medicine, vol. 10, no. 6, pp. 584-592. https://doi.org/10.1016/S2213-2600(21)00486-0